Display options
Cite
Holt SG, Gracey DM, Levy MT, et al. A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. AIDS Res Ther. 2014;11:35doi: 10.1186/1742-6405-11-35.
Holt, S. G., Gracey, D. M., Levy, M. T., Mudge, D. W., Irish, A. B., Walker, R. G., Baer, R., Sevastos, J., Abbas, R., & Boyd, M. A. (2014). A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. AIDS research and therapy, 1135. https://doi.org/10.1186/1742-6405-11-35
Holt, Stephen G, et al. "A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection." AIDS research and therapy vol. 11 (2014): 35. doi: https://doi.org/10.1186/1742-6405-11-35
Holt SG, Gracey DM, Levy MT, Mudge DW, Irish AB, Walker RG, Baer R, Sevastos J, Abbas R, Boyd MA. A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. AIDS Res Ther. 2014 Nov 10;11:35. doi: 10.1186/1742-6405-11-35. eCollection 2014. PMID: 25745499; PMCID: PMC4350301.
Copy Download .nbib Format: NLM
Share it on

AIDS Res Ther. 2014 Nov 10;11:35. doi: 10.1186/1742-6405-11-35. eCollection 2014.

A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection.

AIDS research and therapy

Stephen G Holt, David M Gracey, Miriam T Levy, David W Mudge, Ashley B Irish, Rowan G Walker, Richard Baer, Jacob Sevastos, Riaz Abbas, Mark A Boyd

Affiliations

  1. The Royal Melbourne Hospital and Faculty of Medicine University of Melbourne, 300 Grattan St, Parkville, Melbourne, VIC 3050 Australia.
  2. Royal Prince Alfred Hospital and Central Clinical School, Faculty of Medicine, University of Sydney, Missenden Rd, Camperdown, NSW 2050 Australia.
  3. Liverpool Hospital, Elizabeth St, Liverpool, NSW 2170 Australia.
  4. Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, QLD 4102 Australia.
  5. Royal Perth Hospital, 197 Wellington St, Perth, WA 6000 Australia.
  6. Alfred Hospital, and Department of Medicine, Monash University, Melbourne, VIC 3004 Australia.
  7. Cairns Base Hospital, 165 The Esplanade, Cairns, QLD 4870 Australia.
  8. St. Vincent's Hospital, 390 Victoria Street, Darlinghurst, NSW 2010 Australia.
  9. Medical Affairs, Gilead Sciences, Level 6, 417 St Kilda Road, Melbourne, VIC 3004 Australia.
  10. Kirby Institute, UNSW, Sydney, NSW 2052 Australia.

PMID: 25745499 PMCID: PMC4350301 DOI: 10.1186/1742-6405-11-35

Abstract

A number of antiviral agents used against Human Immunodeficiency Virus (HIV) infection and hepatitis B virus (HBV) mono or co-infection have been associated with real nephrotoxicity (including tenofovir disoproxil fumarate (TDF), atazanavir, indinavir and lopinavir) or apparent changes in renal function (e.g. cobicistat, ritonavir, rilpivirine and dolutegravir). Patients with HIV are at higher risk of acute and chronic renal dysfunction, so baseline assessment and ongoing monitoring of renal function is an important part of routine management of patients with HIV. Given the paucity of evidence in this area, we sought to establish a consensus view on how routine monitoring could be performed in Australian patients on ART regimens, especially those involving TDF. A group of nephrologists and prescribers (an HIV physician and a hepatologist) were assembled by Gilead to discuss practical and reasonable renal management strategies for patients particularly those on TDF-based combination regimens (in the case of those with HIV-infection) or on TDF-monotherapy (in the case of HBV-mono infection). The group considered which investigations should be performed as part of routine practice, their frequency, and when specialist renal referral is warranted. The algorithm presented suggests testing for serum creatinine along with plasma phosphate and an assessment of urinary protein (rather than albumin) and glucose. Here we advocate baseline tests of renal function at initiation of therapy. If creatinine excretion inhibitors (e.g. cobicistat or rilpivirine) are used as part of the ART regimen, we suggest creatinine is rechecked at 4 weeks and this value used as the new baseline. Repeat testing is suggested at 3-monthly intervals for a year and then at least yearly thereafter if no abnormalities are detected. In patients with abnormal baseline results, renal function assessment should be performed at least 6 monthly. In HBV mono-infected patients advocate that a similar testing protocol may be logical.

Keywords: Fanconi syndrome; HIV; Hepatitis B; Monitoring; Renal failure; Tenofovir

References

  1. Nephrol Dial Transplant. 2005 Apr;20(4):743-6 - PubMed
  2. J Hepatol. 2014 Apr;60(4):715-22 - PubMed
  3. AIDS. 2007 Jun 19;21(10):1273-81 - PubMed
  4. Antimicrob Agents Chemother. 2013 Nov;57(11):5612-8 - PubMed
  5. HIV Med. 2014 Jan;15 Suppl 1:1-85 - PubMed
  6. AIDS. 2013 May 15;27(8):1295-302 - PubMed
  7. Antivir Ther. 2013;18(6):793-802 - PubMed
  8. AIDS. 2011 Jul 17;25(11):1421-5 - PubMed
  9. J Infect Dis. 2011 Jul 1;204(1):145-53 - PubMed
  10. Clin Infect Dis. 2010 Sep 1;51(5):496-505 - PubMed
  11. Am J Kidney Dis. 2011 May;57(5):773-80 - PubMed
  12. JAMA. 2012 May 9;307(18):1941-51 - PubMed
  13. Antivir Ther. 2013;18(7):945-8 - PubMed
  14. Nephron Clin Pract. 2009;111(1):c39-48 - PubMed
  15. Nephrol Dial Transplant. 2012 Apr;27(4):1305-13 - PubMed
  16. Curr Opin HIV AIDS. 2013 Nov;8(6):528-34 - PubMed
  17. Med J Aust. 2012 Aug 20;197(4):224-5 - PubMed
  18. Clin Infect Dis. 2005 Jun 1;40(11):1559-85 - PubMed
  19. Physiol Rev. 2011 Apr;91(2):733-94 - PubMed
  20. AIDS Patient Care STDS. 2008 Feb;22(2):99-103 - PubMed
  21. Hepatol Int. 2012 Jun;6(3):531-61 - PubMed
  22. JAMA. 2010 Jul 21;304(3):321-33 - PubMed
  23. J Infect Dis. 2006 Dec 1;194(11):1481-91 - PubMed
  24. Am J Health Syst Pharm. 2011 Jun 1;68(11):991-1001 - PubMed
  25. J Infect Dis. 2014 Aug 1;210(3):363-73 - PubMed
  26. BMJ Case Rep. 2011 Aug 31;2011:null - PubMed
  27. AIDS. 2009 Mar 27;23(6):689-96 - PubMed
  28. Drug Metab Dispos. 2013 Feb;41(2):353-61 - PubMed
  29. BMC Public Health. 2012 Mar 23;12:234 - PubMed
  30. Kidney Int. 2010 Dec;78(11):1171-7 - PubMed
  31. J Infect Dis. 2013 May 1;207(9):1359-69 - PubMed
  32. Antimicrob Agents Chemother. 2002 Mar;46(3):716-23 - PubMed
  33. Nephrol Dial Transplant. 2014 Jun;29(6):1232-8 - PubMed
  34. PLoS One. 2013 Dec 23;8(12):e82028 - PubMed
  35. AIDS. 2013 Mar 27;27(6):939-50 - PubMed
  36. Am J Kidney Dis. 2003 Feb;41(2):292-309 - PubMed
  37. AIDS Res Treat. 2011;2011:354908 - PubMed
  38. HIV Clin Trials. 2007 May-Jun;8(3):164-72 - PubMed
  39. Pharmacogenomics. 2009 Oct;10(10):1675-85 - PubMed
  40. PLoS One. 2012;7(1):e29977 - PubMed
  41. Pharmacotherapy. 2003 Jan;23(1):29-43 - PubMed
  42. Am J Kidney Dis. 2008 Jun;51(6):1052-67 - PubMed
  43. Clin Infect Dis. 2008 Jul 15;47(2):242-9 - PubMed
  44. Kidney Int. 2005 Oct;68(4):1750-8 - PubMed
  45. J Hepatol. 2012 Jul;57(1):167-85 - PubMed
  46. Br J Clin Pharmacol. 2013 Apr;75(4):990-6 - PubMed
  47. Nephrol Dial Transplant. 2012 Apr;27(4):1534-41 - PubMed
  48. J Acquir Immune Defic Syndr. 2012 May 1;60(1):33-42 - PubMed
  49. AIDS. 2012 Apr 24;26(7):867-75 - PubMed
  50. Intern Med J. 2013 Apr;43(4):410-6 - PubMed
  51. Lancet. 2013 Mar 2;381(9868):735-43 - PubMed
  52. AIDS. 2014 Jan 14;28(2):187-99 - PubMed
  53. HIV Med. 2008 Feb;9(2):65-71 - PubMed
  54. N Engl J Med. 2006 Jan 19;354(3):251-60 - PubMed
  55. Curr Opin Infect Dis. 2009 Feb;22(1):43-8 - PubMed
  56. Am J Kidney Dis. 2002 Dec;40(6):1331-3 - PubMed
  57. Br J Pharmacol. 2012 Jun;166(3):1183-91 - PubMed
  58. AIDS. 2008 Oct 18;22(16):2155-63 - PubMed
  59. HIV Med. 2012 Jan;13(1):1-44 - PubMed
  60. AIDS. 2009 Sep 24;23(15):1971-5 - PubMed
  61. AIDS. 2011 Aug 24;25(13):1603-9 - PubMed
  62. HIV Med. 2014 Mar;15(3):144-52 - PubMed
  63. JAMA. 2004 Jul 14;292(2):191-201 - PubMed
  64. J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):32-40 - PubMed
  65. J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):52-8 - PubMed
  66. HIV Med. 2012 Oct;13(9):526-32 - PubMed
  67. Clin Exp Nephrol. 2012 Jun;16(3):363-72 - PubMed
  68. Kidney Int. 2010 Dec;78(11):1060-3 - PubMed
  69. PLoS One. 2012;7(11):e48839 - PubMed

Publication Types